This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To determine whether the use of rhGH therapy in children with X‐linked hypophosphatemia is associated with changes in longitudinal growth, mineral metabolism, endocrine, renal function, bone mineral density, body proportions, and also with any adverse effects.